AbCellera Biologics Inc
(NASDAQ:ABCL)
$5.00
0.09[1.83%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$5.01
0.0100[0.20%]
Open4.930Close5.000
Vol / Avg.2.438M / 2.494MMkt Cap1.447B
Day Range4.880 - 5.00052 Wk Range4.910 - 14.970

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

AbCellera Biologics Stock (NASDAQ:ABCL) Earnings Dates and Earning Calls

AbCellera Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Aug 3

EPS

$-0.110

Quarterly Revenue

$10.1M

Annual Revenue (as of Jun 30)

$145.2M

Earnings History

Analyze the earnings history of AbCellera Biologics using advanced sorting and filters.

Q

When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?

A

AbCellera Biologics (ABCL) is scheduled to report earnings on November 7, 2023. The last reported earnings were for reported on August 3, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for AbCellera Biologics (NASDAQ:ABCL)?

A

The Actual EPS was $-0.11, which beat the estimate of $-0.13.

Q

What were AbCellera Biologics’s (NASDAQ:ABCL) revenues?

A

The Actual Revenue was $10.1M, which missed the estimate of $12.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved